Company intelligence / Profile preview

Goldman Hirsh Partners

Ownership: Private
Development stage: Other

Overview

Goldman Hirsh Partners (operating as Goldman Bio) specializes in developing, integrating, and commercializing Israeli life science technologies with a focus on personalized medicine for cancer. It provides infrastructure and management expertise to advance early-stage innovations from academia to market.

Therapeutic areas: Oncology
Industry: Investors

Beyond the preview

Go deeper on Goldman Hirsh Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Goldman Hirsh Partners.

Explore the full profile